Susan L. Dalrymple
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Ubiquitin and proteasome pathways, Polyamine Metabolism and Applications, Epigenetics and DNA Methylation, Cancer Research and Treatments
Most-Cited Works
- → The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells(2008)233 cited
- → Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer Therapy(2012)216 cited
- → Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models(2003)138 cited
- → Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells(2006)136 cited
- → Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells(2006)131 cited
- → Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment(2012)110 cited
- → Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors(2020)101 cited
- → Pharmacologic Basis for the Enhanced Efficacy of Dutasteride against Prostatic Cancers(2006)99 cited
- → PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor(2006)96 cited
- → Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer(2006)87 cited